Arab Pharmaceuticals

مادة اعلانية

Latest Update: 22 Dec 2024 15:50 Abu Dhabi Time.

Market Status: Closed

ADCI

Arab Pharmaceuticals

141.00

EGP

-1.960

-1.37%

Open

142.96

Prev Close

142.96

PX_VOLUME

1,406

MARKET CAP (M)

DAY RANGE

132.21 - 142.49

52 WEEKS

69.00 - 148.00

Stock Statistics

Yearly Change

105.31%

Listed Shares (Million)

6.00

Earnings Multiple

7.68

Average 30-day trading volume

2,165.08

Price-to-book ratio

1.99

Earnings Per Share

17.14

Previous Dividend Distribution

Dividend Yield

5.84%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Total Revenue		233.33	204.44	167.19	222.66	191.24	148.58
Gross Profit		94.63	68.62	44.23	87.45	65.69	41.79
Operating Income		48.16	23.44	10.37	45.64	33.77	6.73
Profit Margin		15.56	9.94	10.06	17.19	14.34	7.04

	Period Ending:	Jun 30, 2024	Jun 30, 2023
Total Revenue	785.52	633.73
Gross Profit	265.99	224.35
Operating Income	118.10	94.76
Profit Margin	13.09	13.06

Balance Sheet

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Total Assets		1,198.23	1,133.59	1,100.14	1,057.19	732.60	682.07
Total Liabilities		766.75	675.06	657.93	645.23	321.95	298.84
Total Equity		431.48	458.53	442.21	411.96	410.65	383.23

	Period Ending:	Jun 30, 2024	Jun 30, 2023
Total Assets	1,133.59	682.07
Total Liabilities	675.06	298.84
Total Equity	458.53	383.23

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.